Hepatocellular carcinoma with progenitor cell features distinguishable by the hepatic stem/progenitor cell marker NCAM

Cancer Letters

Volumn 309, Issue 1, 2011, Pages 95-103

  Tsuchiya, Atsunori ^a   Kamimura, Hiroteru ^a   Tamura, Yasushi ^a   Takamura, Masaaki ^a   Yamagiwa, Satoshi ^a   Suda, Takeshi ^a   Nomoto, Minoru ^a   Aoyagi, Yutaka ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

FGFR; HCC with progenitor features; Intrahepatic metastasis; NCAM; Soluble NCAM

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR; NERVE CELL ADHESION MOLECULE;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CELL GROWTH; CELL INVASION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; STEM CELL; SURVIVAL TIME;

AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASTIC STEM CELLS; NEURAL CELL ADHESION MOLECULES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEIN ISOFORMS; STEM CELLS; TUMOR MARKERS, BIOLOGICAL;

EID: 79959857869     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.05.021     Document Type: Article

References (26)

1. Kojiro M. Histopathology of liver cancers. Best Pract. Res. Clin. Gastroenterol. 2005, 19:39-62.
2. Komuta M., Spee B., Vander Borght S., De Vos R., Verslype C., Aerts R., Yano H., Suzuki T., Matsuda M., Fujii H., Desmet V.J., Kojiro M., Roskams T. Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin. Hepatology 2008, 47:1544-1556.
3. Roskams T. Liver stem cells and their implication in hepatocellular and cholangiocarcinoma. Oncogene 2006, 25:3818-3822.
4. Wu P.C., Lai V.C., Fang J.W., Gerber M.A., Lai C.L., Lau J.Y. Hepatocellular carcinoma expressing both hepatocellular and biliary markers also expresses cytokeratin 14, a marker of bipotential progenitor cells. J. Hepatol. 1999, 31:965-966.
5. Uenishi T., Kubo S., Yamamoto T., Shuto T., Ogawa M., Tanaka H., Tanaka S., Kaneda K., Hirohashi K. Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence. Cancer Sci. 2003, 94:851-857.
6. Jensen M., Berthold F. Targeting the neural cell adhesion molecule in cancer. Cancer Lett. 2007, 258:9-21.
7. Bourne S.P., Patel K., Walsh F., Popham C.J., Coakham H.B., Kemshead J.T. A monoclonal antibody (ERIC-1), raised against retinoblastoma, that recognizes the neural cell adhesion molecule (NCAM) expressed on brain and tumours arising from the neuroectoderm. J. Neurooncol. 1991, 10:111-119.
8. Mechtersheimer G., Staudter M., Moller P. Expression of the natural killer cell-associated antigens CD56 and CD57 in human neural and striated muscle cells and in their tumors. Cancer Res. 1991, 51:1300-1307.
9. Molenaar W.M., Muntinghe F.L. Expression of neural cell adhesion molecules and neurofilament protein isoforms in skeletal muscle tumors. Hum. Pathol. 1998, 29:1290-1293.
10. Hirano T., Hirohashi S., Kunii T., Noguchi M., Shimosato Y., Hayata Y. Quantitative distribution of cluster 1 small cell lung cancer antigen in cancerous and non-cancerous tissues, cultured cells and sera. Jpn. J. Cancer Res. 1989, 80:348-355.
11. Tassone P., Gozzini A., Goldmacher V., Shammas M.A., Whiteman K.R., Carrasco D.R., Li C., Allam C.K., Venuta S., Anderson K.C., Munshi N.C. In vitro and in vivo activity of the maytansinoid immunoconjugate huN901-N2′-deacetyl-N2′-(3-mercapto-1-oxopropyl)-maytansine against CD56+ multiple myeloma cells. Cancer Res. 2004, 64:4629-4636.
12. Ikushima S., Yoshihara T., Matsumura T., Misawa S., Morioka Y., Hibi S., Imashuku S. Expression of CD56/NCAM on hematopoietic malignant cells. A useful marker for acute monocytic and megakaryocytic leukemias. Int. J. Hematol. 1991, 54:395-403.
13. Hansen S.M., Berezin V., Bock E. Signaling mechanisms of neurite outgrowth induced by the cell adhesion molecules NCAM and N-cadherin. Cell. Mol. Life Sci. 2008, 65:3809-3821.
14. Secher T. Soluble NCAM. Neurochem. Res. 2008.
15. Zhou H., Rogler L.E., Teperman L., Morgan G., Rogler C.E. Identification of hepatocytic and bile ductular cell lineages and candidate stem cells in bipolar ductular reactions in cirrhotic human liver. Hepatology 2007, 45:716-724.
16. Tsuchiya A., Kamimura H., Takamura M., Yamagiwa S., Matsuda Y., Sato Y., Nomoto M., Ichida T., Aoyagi Y. Clinicopathological analysis of CD133 and NCAM human hepatic stem/progenitor cells in damaged livers and hepatocellular carcinomas. Hepatol. Res. 2009, 39:1080-1090.
17. Murakami K., Sakukawa R., Ikeda T., Matsuura T., Hasumura S., Nagamori S., Yamada Y., Saiki I. Invasiveness of hepatocellular carcinoma cell lines: contribution of membrane-type 1 matrix metalloproteinase. Neoplasia 1999, 1:424-430.
18. Van Eyken P., Sciot R., Paterson A., Callea F., Kew M.C., Desmet V.J. Cytokeratin expression in hepatocellular carcinoma: an immunohistochemical study. Hum. Pathol. 1988, 19:562-568.
19. Zhuang P.Y., Zhang J.B., Zhu X.D., Zhang W., Wu W.Z., Tan Y.S., Hou J., Tang Z.Y., Qin L.X., Sun H.C. Two pathologic types of hepatocellular carcinoma with lymph node metastasis with distinct prognosis on the basis of CK19 expression in tumor. Cancer 2008, 112:2740-2748.
20. Ding S.J., Li Y., Tan Y.X., Jiang M.R., Tian B., Liu Y.K., Shao X.X., Ye S.L., Wu J.R., Zeng R., Wang H.Y., Tang Z.Y., Xia Q.C. From proteomic analysis to clinical significance: overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasis. Mol. Cell. Proteomics 2004, 3:73-81.
21. Campodonico P.B., de Kier Joffe E.D., Urtreger A.J., Lauria L.S., Lastiri J.M., Puricelli L.I., Todaro L.B. The neural cell adhesion molecule is involved in the metastatic capacity in a murine model of lung cancer. Mol. Carcinog. 2010, 49:386-397.
22. Gascon E., Vutskits L., Kiss J.Z. The role of PSA-NCAM in adult neurogenesis. Neurochem. Res. 2008.
23. El Maarouf A., Rutishauser U. Use of PSA-NCAM in repair of the central nervous system. Neurochem. Res. 2008.
24. Lehembre F., Yilmaz M., Wicki A., Schomber T., Strittmatter K., Ziegler D., Kren A., Went P., Derksen P.W., Berns A., Jonkers J., Christofori G. NCAM-induced focal adhesion assembly: a functional switch upon loss of E-cadherin. EMBO J. 2008, 27:2603-2615.
25. Frame M.C., Inman G.J. NCAM is at the heart of reciprocal regulation of E-cadherin- and integrin-mediated adhesions via signaling modulation. Dev. Cell 2008, 15:494-496.
26. Grange C., Geninatti-Crich S., Esposito G., Alberti D., Tei L., Bussolati B., Aime S., Camussi G. Combined delivery and magnetic resonance imaging of neural cell adhesion molecule-targeted doxorubicin-containing liposomes in experimentally induced Kaposi's sarcoma. Cancer Res. 2010, 70:2180-2190.